Product information

From Health Canada

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Dormant

Current status date:

2024-05-01

Original market date: See footnote 1

1996-09-26

Product name:

ZITHROMAX - PWS ORL 100MG/5ML

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

02223716

Product Monograph/Veterinary Labelling:

Date: 2023-04-27 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

PFIZER CANADA ULC
17300 Trans-Canada Highway
Kirkland
Quebec
Canada H9J 2M5

Class:

Human

Dosage form(s):

Powder For Suspension

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

08:12.12.92 

Anatomical Therapeutic Chemical (ATC): See footnote 4

J01FA10 AZITHROMYCIN

Active ingredient group (AIG) number:See footnote5

0126072002

List of active ingredient(s)
Active ingredient(s) Strength
AZITHROMYCIN 100 MG / 5 ML
Version 4.0.2
Date modified: